Results Of The Prospective, Multicenter, Single-Arm, Open-Label, Phase 4 Motion Study Of Riociguat In Pulmonary Arterial Hypertension

被引：0
|
作者：
Sood, N. [1 ]
Aranda, A. [2 ]
Platt, D. M. [3 ]
LaRose, A. [3 ]
Kleinjung, F. [4 ]
O'Brien, G. [3 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Allianze Pulm Grp, Guaynabo, PR USA
[3] Bayer Healthcare Pharmaceut, Whippany, NJ USA
[4] Bayer Pharma AG, Berlin, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2287
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Baseline Demographics Of The Prospective, Multicenter, Single-Arm, Open-Label, Phase Iv Motion Study Of Riociguat In Pulmonary Arterial Hypertension
    Sood, N.
    Aranda, A.
    Mobin, S.
    Platt, D.
    O'Brien, G.
    Satler, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [2] Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment
    Mathai, Stephen C.
    Minai, Omar
    Sullivan, Sean D.
    Lerner, Debra
    Levine, Deborah
    [J]. RESPIRATORY MEDICINE, 2017, 122 : S23 - S27
  • [3] Initial Combination Therapy With Riociguat and Ambrisentan in Pulmonary Arterial Hypertension: A Prospective Open-label Study
    Thakrar, M. V.
    Weatherald, J. C.
    Varughese, R. A.
    Helmersen, D. S.
    Lydell, C.
    Fine, N.
    Hirani, N.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S53 - S54
  • [4] The SPECTRA Study: A Phase 2a Single-Arm, Open-Label, Multicenter Exploratory Study to Assess the Effects of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
    Waxman, A. B.
    Risbano, M. G.
    Frantz, R. P.
    Manimaran, S.
    Lu, J.
    Rischard, F.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [5] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
    Shuichi Ito
    Yuya Nishiyama
    Kenkichi Sugiura
    Kazuaki Enya
    [J]. Clinical and Experimental Nephrology, 2022, 26 : 350 - 358
  • [6] Sirolimus treatment for intractable lymphatic anomalies: an open-label, single-arm, multicenter, prospective trial
    Ozeki, Michio
    Endo, Saori
    Yasue, Shiho
    Nozawa, Akifumi
    Asada, Ryuta
    Saito, Akiko M.
    Hashimoto, Hiroya
    Fujimura, Takumi
    Yamada, Yohei
    Kuroda, Tatsuo
    Ueno, Shigeru
    Watanabe, Shoji
    Nosaka, Shunsuke
    Miyasaka, Mikiko
    Umezawa, Akihiro
    Matsuoka, Kentaro
    Maekawa, Takanobu
    Hirakawa, Satoshi
    Furukawa, Taizo
    Fumino, Shigehisa
    Tajiri, Tatsuro
    Takemoto, Junkichi
    Souzaki, Ryota
    Kinoshita, Yoshiaki
    Fujino, Akihiro
    [J]. FRONTIERS IN MEDICINE, 2024, 11
  • [7] Sirolimus Treatment for Intractable Vascular Anomalies: An Interim Analysis of an Open-Label, Single-Arm, Multicenter, Prospective Study
    Ozeki, Michio
    Nozawa, Akifumi
    Yasue, Shiho
    Endo, Saori
    Asada, Ryuta
    Hashimoto, Hiroya
    Sozaki, Ryota
    Fumino, Shigehisa
    Furukawa, Taizo
    Tajiri, Tatsuro
    Fukao, Toshiyuki
    [J]. PEDIATRIC BLOOD & CANCER, 2019, 66 : S5 - S5
  • [8] Rituximab therapy for intractable pemphigus: A multicenter, open-label, single-arm, prospective study of 20 Japanese patients
    Yamagami, Jun
    Kurihara, Yuichi
    Funakoshi, Takeru
    Saito, Yasuko
    Tanaka, Ryo
    Takahashi, Hayato
    Ujiie, Hideyuki
    Iwata, Hiroaki
    Hirai, Yoji
    Iwatsuki, Keiji
    Ishii, Norito
    Sakurai, Jun
    Abe, Takayuki
    Takemura, Ryo
    Mashino, Naomi
    Abe, Masahiro
    Amagai, Masayuki
    [J]. JOURNAL OF DERMATOLOGY, 2023, 50 (02): : 175 - 182
  • [9] Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial
    Weatherald, Jason
    Thakrar, Mitesh, V
    Varughese, Rhea A.
    Kularatne, Mithum
    Liu, Jonathan
    Harper, Lea
    Kiamanesh, Omid
    Fine, Nowell
    Orlikow, Evan
    Nwaroh, Chidera
    Thornton, Christina
    Swiston, John
    Kolkman, Lisa
    Brunner, Nathan W.
    Helmersen, Doug
    Hirani, Naushad
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (05): : 563 - 567
  • [10] An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma
    Agulnik, Mark
    Schulte, Brian
    Robinson, Steven
    Hirbe, Angela C.
    Kozak, Kevin
    Chawla, Sant P.
    Attia, Steven
    Rademaker, Alfred
    Zhang, Hui
    Abbinanti, Susan
    Cehic, Rasima
    Monga, Varun
    Milhem, Mohammed
    Okuno, Scott
    Van Tine, Brian A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2021, 154 : 201 - 208
12345